SCHEMBL13613733

SCHEMBL13613733

COC(=O)[C@H](CC(C)C)N(CCC(CNC(=O)OC(C)(C)C)N[C@@H](Cc1ccccc1)C(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.47
POLB P06746 2/20 0.42
GPR55 Q9Y2T6 1/20 0.42
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MEN1 O00255 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
REN P00797 2/20 0.40
PSEN1 P49768 4/20 0.40
PSEN2 P49810 4/20 0.40
APH1B Q8WW43 4/20 0.40
NCSTN Q92542 4/20 0.40
APH1A Q96BI3 4/20 0.40
PSENEN Q9NZ42 4/20 0.40
CAPN1 P07384 1/20 0.40
MAPK1 P28482 1/20 0.40
CTSL P07711 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12880614 0.83 SYK (0.51) SYKPOLBGPR55MAPTKDM4E
SCHEMBL13613734 0.79 SYK (0.44) SYKPOLBGPR55MAPTKDM4E
SCHEMBL30841401 0.76 SYK (0.48) SYKPOLBMAPTKDM4ETDP1
SCHEMBL10705796 0.75 SYK (0.54) SYKPOLBGPR55MAPTKDM4E
SCHEMBL16318175 0.74 CAPN1 (0.46) SYKPSEN1PSEN2APH1BNCSTN
SCHEMBL30841403 0.73 SYK (0.47) SYKPOLBMAPTMEN1KMT2A
SCHEMBL12189898 0.73 SYK (0.53) SYKPOLBMAPTMEN1RECQL
SCHEMBL30841335 0.72 SYK (0.44) SYKPOLBMAPTKDM4ETDP1
SCHEMBL30841384 0.72 SYK (0.45) SYKPOLBMAPTMAPK1CTSK
SCHEMBL30841405 0.72 SYK (0.45) SYKPOLBMAPTMEN1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275727-A1 Peptide turn mimetics MIMETICA PTY LIMITED (AU) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275727-A1 Peptide turn mimetics IAPP, GLP1R, VIP SYK 3770/4885POLB 2326/4885GPR55 4169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.